The scatterplots showed that, as the expression of COL17A1/GBP4/CDC6 increased and the risk score increased, the survival time of each pancreatic cancer patient decreased and the proportion of death increased (Figure 2A). This evidence concerns the gene CDC6 and familial pancreatic carcinoma.